Outcome of CentriMag ™ extracorporeal mechanical circulatory support use in critical cardiogenic shock (INTERMACS 1) patients
ConclusionOur results demonstrate an excellent outcome with the use of the CentriMag ™ device in this seriously ill population. Despite requiring multiple procedures, over 58% of patients were discharged from hospital with 5-year survival of 46%.
Source: Indian Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
More News: Bleeding | Cardiogenic Shock | Cardiology | Cardiomyopathy | Cardiovascular | Cardiovascular & Thoracic Surgery | Dialysis | Dilated Cardiomyopathy | Fungal Infections | Heart | Heart Transplant | India Health | Ischemic Stroke | Myocarditis | Renal Failure | Stroke | Study | Transplants